Beneficial effect of methylprednisolone after mandibular third molar surgery: a randomized, double-blind, placebo-controlled split-mouth trial
- 449 Downloads
Third molar (M3) removal is the model most frequently used for pain trials in oral surgery. Corticosteroids are frequently administered to reduce trismus and swelling after dentoalveolar surgical procedures. The purpose of this investigation was to evaluate the influence of a single, preoperative oral application of methylprednisolone on postoperative trismus, pain intensity, and the subjective need for analgesic medication after surgical removal of impacted mandibular M3 (LM3).
Materials and methods
Sixteen healthy patients requiring similar bilateral surgical LM3 removal were included in a prospective, randomized, placebo-controlled, double-blind study in a split-mouth design. At random, each patient received either weight-dependent methylprednisolone (40–80 mg) or a placebo orally 1 h prior to surgery. In each case, the right and left LM3 were treated in independent visits. Trismus, swelling, pain measured on a 100-mm visual analog scale, and the postoperative demand of analgesics were assessed.
Statistical analysis indicates a significant reduction of trismus, swelling, pain intensity, and patient-controlled intake of analgesics during the whole postsurgical period of investigation (first to seventh day).
The results of this study suggest that a single preoperative weight-dependent administration of methylprednisolone is a safe and effective concept for diminishing postoperative discomfort, pain intensity, and the total intake of analgesics after wisdom tooth extractions.
In case of missing contraindications, the preoperative administration of methylprednisolone is recommended, a routine medication for more extended procedures in oral surgery.
KeywordsThird molar surgery Methylprednisolone Corticosteroids Postsurgical pain Analgesic therapy
The biometric evaluations were performed by DI Irene Mischak, statistician at the University-Dental-Clinic of Medical University Graz.
Conflict of interest
The authors declare that they have no conflict of interest.
- 6.Douglass LJ (1999) Determination of the anti-Inflammatory effects of methylprednisolone on the sequelae of third molar surgery. J Oral Maxillofac Surg 57:1206–1208Google Scholar
- 9.Kim K, Brar P, Jakubowski J, Kaltman S, Lopez E (2009) The use of corticosteroids and nonsteroidal anti-inflammatory medication for the management of pain and inflammation after third molar surgery: a review of the literature. Oral Surg Oral Med oral Pathol Oral Radiol Endod 107:630–640PubMedCrossRefGoogle Scholar
- 19.Kawamura M, Hatanaka K, Saito M, Ogino M, Ono T, Ogino K, Matsuo S, Harada Y (2000) Are the anti-inflammatory effects of dexamethasone responsible for inhibition of the induction of enzymes involved in prostanoid formation in rat carrageenin-induced pleurisy? Eur J Pharmacol 400:127–135PubMedCrossRefGoogle Scholar
- 21.Filho JRL, Maurette PE, Allais M, Cotinho M, Fernandes C (2008) Clinical comparative study of the effectiveness of two dosages of dexamethasone to control postoperative swelling, trismus and pain after the surgical extraction of mandibular impacted third molars. Med Oral Pathol Oral Cir Bucal 13:E129–E132Google Scholar
- 24.Pederson GW (1988) Oral surgery. WB Saunders, Philadelphia, Cited in: Koerner KR. The removal of impacted third molars—principles and procedures. Dent Clin North Am 1994;38:255–278Google Scholar
- 25.Krogh-Poulsen WG, Olsson A (1966) Occlusal disharmonies and dysfunction of the stomatognathic system. Dent Clin North Am 11:627–635Google Scholar
- 30.Huffmann G (1977) Use of methylprednisolone sodium succinate to reduce postoperative edema after removal of impacted third molars. J Oral Surg 35:198–199Google Scholar